Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Editor In Chief, Pharma, APAC
Japan
+33 year(s) experience
Scrip
In this week's podcast version of Five Must-Know Things, hear about adenovirus vaccines and blood clots, Lilly’s new moves in genetic diseases, the efficacy debate over Chinese COVID-19 vaccines, putting a price tag on innovation, and Sanofi’s bullishness on IL-2.
Scrip
In this week's podcast version of Five Must-Know Things, hear about whether safety concerns may affect JAK inhibitors, Takeda’s strategic R&D plans, Cigna’s psoriasis insurance program, Phase III readouts to look for, and an overview of the global pharma R&D pipeline.
Scrip
In this week's podcast version of Five Must-Know Things, hear about new results for Lilly in Alzheimer’s, a US delay for AbbVie, progress for Zolgensma in the UK, challenges for AstraZeneca’s coronavirus vaccine, and a Scrip roundtable on industry lessons from the pandemic.
Scrip
In this week's podcast version of Five Must-Know Things, hear about Roche's deal-making in a pandemic, coronavirus vaccine disinformation, Amgen’s Five Prime acquisition, a Novartis clinical trial failure, and new data for a Merck antiviral for the coronavirus.
Scrip
A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.
Topic BioPharmaceutical
Scrip
Join us for an audio catch-up on the major events in the global biopharma industry over the past business week, as reported by Scrip's worldwide team, in this podcast version of Five Must-Know Things.
Scrip
Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
Scrip
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things
Scrip
As part of broader efforts to pursue novel approaches to common neurological disorders, Eisai uses iPSC-derived cells to help identify potential new drug therapies for Parkinson's.
Topic Parkinson's Disease
Scrip
Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.
Topic Coronavirus M A
Scrip
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Topic Sales Earnings
Scrip
Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team
Scrip
Join us for an audio roundup of major events in the international biopharma industry over the past week, as covered by Scrip's global team
Scrip
Join us for an audio roundup of major events in the international biopharma industry over the past week, as reported by Scrip's global team
Topic Coronavirus Clinical Trials
Scrip
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.
Pink Sheet
13 May 2021
Scrip
11 May 2021
Scrip
10 May 2021
Scrip
06 May 2021
Scrip
12 Apr 2021
Scrip
07 Apr 2021
Scrip
05 Apr 2021
Scrip
11 Mar 2021
Pink Sheet
09 Mar 2021
Scrip
05 Mar 2021
Scrip
03 Mar 2021
Scrip
25 Feb 2021
Pink Sheet
19 Feb 2021
Scrip
17 Feb 2021
Scrip
16 Feb 2021
